Radiation recall gastritis secondary to combination of gemcitabine and erlotinib in pancreatic cancer and response to PPI - a case report
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Radiation recall gastritis secondary to combination of gemcitabine and erlotinib in pancreatic cancer and response to PPI - a case report ; volume:16 ; number:1 ; day:2 ; month:8 ; year:2016 ; pages:1-4 ; date:12.2016
BMC cancer ; 16, Heft 1 (2.8.2016), 1-4, 12.2016
- Urheber
-
Choi, Seong Ji
- Beteiligte Personen und Organisationen
-
Kim, Hyo Jung
Kim, Jae Seon
Bak, Young-Tae
Kim, Jun Suk
SpringerLink (Online service)
- DOI
-
10.1186/s12885-016-2616-3
- URN
-
urn:nbn:de:1111-20160804862
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Choi, Seong Ji
- Kim, Hyo Jung
- Kim, Jae Seon
- Bak, Young-Tae
- Kim, Jun Suk
- SpringerLink (Online service)
Ähnliche Objekte (12)
Erlotinib plus gemcitabine versus gemcitabine for pancreatic cancer: real-world analysis of Korean national database
Gemcitabine-Induced Radiation Recall Myositis: Case Report and Review of the Literature
ZiPPi
Randomized, phase I/II study of gemcitabine plus IGF-1R antagonist (MK-0646) versus gemcitabine plus erlotinib with and without MK-0646 for advanced pancreatic adenocarcinoma
Gastritis
Gastritis
Gastritis
Gastritis
A phase I trial investigating pulsatile erlotinib in combination with gemcitabine and oxaliplatin in advanced biliary tract cancers
Total Recall : Total recall
Erlotinib in pancreatic cancer
Perhimpunan Peladjar Indonesia (PPI)
Erlotinib plus gemcitabine versus gemcitabine for pancreatic cancer: real-world analysis of Korean national database
Gemcitabine-Induced Radiation Recall Myositis: Case Report and Review of the Literature
ZiPPi
Randomized, phase I/II study of gemcitabine plus IGF-1R antagonist (MK-0646) versus gemcitabine plus erlotinib with and without MK-0646 for advanced pancreatic adenocarcinoma
Gastritis
Gastritis
Gastritis
Gastritis
A phase I trial investigating pulsatile erlotinib in combination with gemcitabine and oxaliplatin in advanced biliary tract cancers
Total Recall : Total recall
Erlotinib in pancreatic cancer
Perhimpunan Peladjar Indonesia (PPI)
Erlotinib plus gemcitabine versus gemcitabine for pancreatic cancer: real-world analysis of Korean national database
Gemcitabine-Induced Radiation Recall Myositis: Case Report and Review of the Literature
ZiPPi
Randomized, phase I/II study of gemcitabine plus IGF-1R antagonist (MK-0646) versus gemcitabine plus erlotinib with and without MK-0646 for advanced pancreatic adenocarcinoma
Gastritis
Gastritis
Gastritis
Gastritis
A phase I trial investigating pulsatile erlotinib in combination with gemcitabine and oxaliplatin in advanced biliary tract cancers
Total Recall : Total recall
Erlotinib in pancreatic cancer